High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel Present, MD
Icahn School of Medicine at Mount Sinai
Principal Investigator - David P. Jacobus, MD
Jacobus Pharmaceutical
Study Chair - Iris Dotan, MD
Tel-Aviv Sourasky Medical Center
Principal Investigator - John Hanson, MD
Charlotte Gastroenterology & Hepatology, PLLC
Principal Investigator - Kathy L. Ales, MD
Jacobus Pharmaceutical
Study Director - Rami Eliakim, MD
Rambam Health Care Campus
Principal Investigator - Stephen B. Hanauer, MD
University of Chicago Hospitals
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rambam Medical Center
Haifa, Israel
- Tel-Aviv Sourasky Medical Center
Tel Aviv, Israel
- the University of Chicago
Chicago, Illinois, United States
- Mount Sinai School of Medicine Ibd Research Center
New York, New York, United States
- Charlotte Gastroenterology and Hepatology, Pllc
Charlotte, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2007
- Primary completion
- 31 Dec 2007
- Completion
- 31 Oct 2008
- Last update posted
- 15 Oct 2008
- Registered enrollment
- 54
- Registry id
- NCT00417690
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.